Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ. READ MORE

News

Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ.

READ MORE

Obinutuzumab combined with bendamustine is more effective than bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.

READ MORE

Obinutuzumab may improve survival and lower the risk of worsening disease compared with rituximab in patients with follicular lymphoma.

READ MORE

A study compared seven prophylaxis strategies for reducing the risk of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy.

READ MORE

Research in Review

The ability of chimeric antigen receptor T-cells to perform multiple functions is associated with improved outcomes for advanced non-Hodgkin lymphoma.

READ MORE